Early driver of prostate cancer aggressiveness
ANN ARBOR, Mich. — For decades, the primary strategy in the fight against advanced prostate cancer has centered on a single biological vulnerability: the...
Press Enter to Search or ESC to Close
ANN ARBOR, Mich. — For decades, the primary strategy in the fight against advanced prostate cancer has centered on a single biological vulnerability: the androgen receptor. By starving tumors of the hormones they need to grow, clinicians have been able to extend the lives of countless patients. However, cancer is a master of adaptation, and […]
In a significant advancement for the field of oncology, researchers at the University of Michigan Rogel Cancer Center have identified a specific gene that serves as a primary driver in the development of aggressive, treatment-resistant prostate cancer. The discovery not only sheds light on the biological mechanisms that allow cancer cells to evade standard therapies […]